会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Rubyrin and related expanded porphyrins
    • Rubyrin和相关的扩展卟啉
    • US5410045A
    • 1995-04-25
    • US15208
    • 1993-02-09
    • Jonathan L. SesslerTakashi MorishimaSteven J. Weghorn
    • Jonathan L. SesslerTakashi MorishimaSteven J. Weghorn
    • C07D487/22C07D519/00C07H15/26C07H19/16
    • C07H19/16C07D487/22C07D519/00C07H15/26
    • The present invention is directed to the synthesis and use of novel macrocyclic compounds, based upon a new class of expanded porphyrins, termed rubyrins. Disclosed herein is the structure and synthesis of a prototypical rubyrin and various substituted rubyrin analogues, conjugates and compositions. Rubyrin itself is characterized by the presence of six pyrrolic subunits contained within a fully aromatic 26 .pi.-electron macrocyclic framework and by UV/VIS absorption bands that are very red-shifted as compared to those of other porphyrins or pentapyrrolic expanded porphyrins. The rubyrin-type class of compounds is further characterized by an ability to undergo facile protonation at the pyrrolic nitrogens and, once protonated, by an ability to form complexes with anions such as nucleotide-containing compounds. Rubyrin-based compounds are useful as, for example, anion chelators and receptors and as transporters for various anionic compounds including antiviral agents. In addition to the 26 .pi.-electron target system, the present invention concerns other oxidation states bearing the same connectivity and the same total number of non-hydrogen atoms, and various analogues in which different substituents are present at the various meso and/or .beta.-pyrrolic positions or in which furan and/or thiophene moieties replace one or more of the six pyrrolic subunits.
    • 本发明涉及新型大环化合物的合成和应用,其基于新类型的称为红宝石的扩展卟啉。 本文公开了原型红宝石和各种取代的rubyrin类似物,缀合物和组合物的结构和合成。 Rubyrin本身的特征在于含有完全芳香族26电子大环框架中的六个吡咯亚基和与其它卟啉或五吡咯基扩展的卟啉相比非常红移的UV / VIS吸收带。 红霉素类化合物的进一步特征在于能够在吡咯氮下进行容易的质子化,并且一旦被质子化,就可以通过与阴离子如含核苷酸的化合物形成络合物的能力。 基于Rubyrin的化合物可用作例如阴离子螯合剂和受体以及作为包括抗病毒剂的各种阴离子化合物的转运蛋白。 除了26p1电子靶系统之外,本发明涉及具有相同连接性和相同总数的非氢原子的其它氧化态,以及各种不同取代基存在于各种中和和/或β的各种类似物 呋喃和/或噻吩部分取代六个吡咯亚基中的一个或多个。
    • 3. 发明授权
    • Thermal dye transfer sheet and method for thermal dye recording
    • 热染料转印片和热染料记录方法
    • US5916842A
    • 1999-06-29
    • US839804
    • 1997-04-18
    • Tatsuya MorimitsuKenjiro KurodaOsamu ItoTakashi Morishima
    • Tatsuya MorimitsuKenjiro KurodaOsamu ItoTakashi Morishima
    • B41M5/035B41M5/385B41M5/388B41M5/39B41M5/38
    • B41M5/3854B41M2205/02B41M5/385B41M5/3858B41M5/388B41M5/39Y10S428/913Y10S428/914
    • A thermal dye transfer sheet having a dye layer provided on at least one side of a substrate, which is used for thermal dye transfer recording system carrying out recording by transferring a dye or dyes in the dye layer to a dye-receiving material by heating means, wherein the dye layer contains a pyrazolonemethine type dye of the following formula: ##STR1## wherein R.sup.1 and R.sup.2 can be respectively independently selected and are a lower alkyl group which may be substituted, a lower alkenyl group which may be substituted or an aryl group which may be substituted; andR.sup.3 and R.sup.4 can be respectively independently selected and are a lower alkyl group which may be substituted, a dialkylamino group, a --COOR.sup.5 group or a --CONR.sup.6 R.sup.7 group, in which R.sup.5 is a lower alkyl group which may be substituted, a lower alkenyl group which may be substituted or an aryl group which may be substituted and R.sup.6 and R.sup.7 can be respectively independently selected and are a hydrogen atom, a lower alkyl group which may be substituted, a lower alkenyl group which may be substituted or an aryl group which may be substituted.
    • 一种具有设置在基材的至少一侧的染料层的热染料转印片,其用于通过将染料层中的染料或染料转移到染料接收材料的加热装置进行记录的热染料转印记录系统 其中染料层含有下式的吡唑啉酮类染料:其中R1和R2可以分别独立选择,可以被取代的低级烷基,可被取代的低级烯基或可以被取代的芳基 取代 R 3和R 4可分别独立选择,可以被取代的低级烷基,二烷基氨基,-COOR 5基或-CONR 6 R 7基,其中R 5为可被取代的低级烷基,低级烯基 可以被取代的基团或可以被取代的芳基,R 6和R 7可以分别独立地选择并且是氢原子,可被取代的低级烷基,可被取代的低级烯基或芳基, 可以被替代。
    • 4. 发明授权
    • Rubyrin macrocycles
    • Rubyrin大环
    • US5622945A
    • 1997-04-22
    • US368336
    • 1995-01-04
    • Jonathan L. SesslerTakashi MorishimaSteven J. Weghorn
    • Jonathan L. SesslerTakashi MorishimaSteven J. Weghorn
    • C07D487/22C07D519/00C07H15/26C07H19/16A61K31/395
    • C07H19/16C07D487/22C07D519/00C07H15/26
    • The present invention is directed to the synthesis and use of novel macrocyclic compounds, based upon a new class of expanded porphyrins, termed rubyrins. Disclosed herein is the structure and synthesis of a prototypical rubyrin and various substituted rubyrin analogues, conjugates and compositions. Rubyrin itself is characterized by the presence of six pyrrolic subunits contained within a fully aromatic 26 .pi.-electron macrocyclic framework and by UV/VIS absorption bands that are very red-shifted as compared to those of other porphyrins or pentapyrrolic expanded porphyrins. The rubyrin-type class of compounds is further characterized by an ability to undergo facile protonation at the pyrrolic nitrogens and, once protonated, by an ability to form complexes with anions such as nucleotide-containing compounds. Rubyrin-based compounds are useful as, for example, anion chelators and receptors and as transporters for various anionic compounds including antiviral agents. In addition to the 26 .pi.-electron target system, the present invention concerns other oxidation states bearing the same connectivity and the same total number of non-hydrogen atoms, and various analogues in which different substituents are present at the various meso and/or .beta.-pyrrolic positions or in which furan and/or thiophene moieties replace one or more of the six pyrrolic subunits.
    • 本发明涉及新型大环化合物的合成和应用,其基于新类型的称为红宝石的扩展卟啉。 本文公开了原型红宝石和各种取代的rubyrin类似物,缀合物和组合物的结构和合成。 Rubyrin本身的特征在于含有完全芳香族26电子大环框架中的六个吡咯亚基和与其它卟啉或五吡咯基扩展的卟啉相比非常红移的UV / VIS吸收带。 红霉素类化合物的进一步特征在于能够在吡咯氮下进行容易的质子化,并且一旦被质子化,就可以通过与阴离子如含核苷酸的化合物形成络合物的能力。 基于Rubyrin的化合物可用作例如阴离子螯合剂和受体以及作为包括抗病毒剂的各种阴离子化合物的转运蛋白。 除了26p1电子靶系统之外,本发明涉及具有相同连接性和相同总数的非氢原子的其它氧化态,以及各种不同取代基存在于各种中和和/或β的各种类似物 呋喃和/或噻吩部分取代六个吡咯亚基中的一个或多个。